Radiotherapy dose and fractionation for stage III NSCLC

Lancet Oncol. 2015 Apr;16(4):e156-7. doi: 10.1016/S1470-2045(15)70121-X.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adenocarcinoma / therapy*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Large Cell / therapy*
  • Carcinoma, Non-Small-Cell Lung / therapy*
  • Carcinoma, Squamous Cell / therapy*
  • Chemoradiotherapy*
  • Female
  • Humans
  • Lung Neoplasms / therapy*
  • Male